Sectoral Asset Management Inc Replimune Group, Inc. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $231,903 - $555,880	34,356 Added 12.67%	305,412 $2.57 Million
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $518,939 - $721,182	32,515 Added 13.63%	271,056 $4.64 Million
Q2 2023 Aug 11, 2023	SELL	$15.65 - $24.1 $370,263 - $570,181	-23,659 Reduced 9.02%	238,541 $5.54 Million
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $1.15 Million - $1.91 Million	65,700 Added 33.44%	262,200 $4.63 Million
Q4 2022 Feb 10, 2023	BUY	$17.09 - $27.91 $3.36 Million - $5.48 Million	196,500 New	196,500 $5.34 Million
Q1 2021 May 14, 2021	SELL	$30.22 - $45.57 $20.2 Million - $30.4 Million	-667,729 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$23.5 - $52.65 $15.7 Million - $35.2 Million	667,729 New	667,729 $25.5 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.